Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3368)
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
11,000
Price
$61.88
Total Value
$680.68K
Shares Held After
50,440
% of Holdings
17.9%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
15,000
Price
$61.87
Total Value
$928.05K
Shares Held After
61,440
% of Holdings
19.6%
INSMED Inc (INSM)
Lewis William — Director
Shares
2,128
Price
$147.54
Total Value
$313.97K
Shares Held After
301,185
% of Holdings
0.7%
INSMED Inc (INSM)
Lewis William — Director
Shares
3,899
Price
$146.66
Total Value
$571.83K
Shares Held After
303,313
% of Holdings
1.3%
INSMED Inc (INSM)
Lewis William — Director
Shares
2,589
Price
$145.27
Total Value
$376.10K
Shares Held After
307,212
% of Holdings
0.8%
INSMED Inc (INSM)
Lewis William — Director
Shares
2,083
Price
$144.23
Total Value
$300.43K
Shares Held After
309,801
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
200
Price
$487.65
Total Value
$97.53K
Shares Held After
36,844
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
743
Price
$486.52
Total Value
$361.48K
Shares Held After
37,044
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,006
Price
$485.32
Total Value
$488.24K
Shares Held After
37,787
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,398
Price
$484.55
Total Value
$677.40K
Shares Held After
38,793
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,086
Price
$483.54
Total Value
$525.12K
Shares Held After
40,191
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,177
Price
$482.68
Total Value
$568.11K
Shares Held After
41,277
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
720
Price
$481.33
Total Value
$346.56K
Shares Held After
42,454
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,602
Price
$480.22
Total Value
$769.31K
Shares Held After
43,174
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
368
Price
$479.43
Total Value
$176.43K
Shares Held After
44,776
% of Holdings
0.8%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
50,000
Price
$19.22
Total Value
$961.05K
Shares Held After
964,161
% of Holdings
4.9%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
153
Price
$326.24
Total Value
$49.91K
Shares Held After
20,569
% of Holdings
0.7%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
148
Price
$324.60
Total Value
$48.04K
Shares Held After
20,722
% of Holdings
0.7%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
233
Price
$323.25
Total Value
$75.32K
Shares Held After
20,870
% of Holdings
1.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
124
Price
$321.81
Total Value
$39.90K
Shares Held After
21,103
% of Holdings
0.6%
Edesa Biotech, Inc. (EDSA)
Nijhawan Pardeep — Director
Shares
10,000
Price
$3.90
Total Value
$39.00K
Shares Held After
402,702
% of Holdings
2.5%
Dyne Therapeutics, Inc. (DYN)
Friedl-Naderer Johanna — Chief Commercial Officer
Shares
148
Price
$14.90
Total Value
$2.21K
Shares Held After
154,581
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
500
Price
$326.08
Total Value
$163.04K
Shares Held After
18,693
% of Holdings
2.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
510
Price
$324.59
Total Value
$165.54K
Shares Held After
19,193
% of Holdings
2.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
740
Price
$323.55
Total Value
$239.43K
Shares Held After
19,703
% of Holdings
3.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
654
Price
$322.33
Total Value
$210.80K
Shares Held After
20,443
% of Holdings
3.1%
Zai Lab Ltd (ZLAB)
Edmondson Frazor Titus III — Chief Legal Officer
Shares
15,569
Price
$19.06
Total Value
$296.75K
Shares Held After
3,517
% of Holdings
81.6%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Viswanadhan Krishnan — Chief Corp Dev & Strategy
Shares
2,959
Price
$27.80
Total Value
$82.26K
Shares Held After
5,141
% of Holdings
36.5%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
3,989
Price
$63.38
Total Value
$252.82K
Shares Held After
2,737
% of Holdings
59.3%
Metagenomi Therapeutics, Inc. (MGX)
Wapnick Pamela — Chief Financial Officer
Shares
1,581
Price
$1.60
Total Value
$2.53K
Shares Held After
187,375
% of Holdings
0.8%
Xencor Inc (XNCR)
Dahiyat Bassil I — Director
Shares
14,870
Price
$11.25
Total Value
$167.22K
Shares Held After
552,922
% of Holdings
2.6%
PTC THERAPEUTICS, INC. (PTCT)
Okey Stephanie — Director
Shares
6,333
Price
$63.38
Total Value
$401.39K
Shares Held After
8,000
% of Holdings
44.2%
Xencor Inc (XNCR)
Eckert Celia — SVP, GENERAL COUNSEL
Shares
3,244
Price
$11.25
Total Value
$36.48K
Shares Held After
78,685
% of Holdings
4.0%
Metagenomi Therapeutics, Inc. (MGX)
Irish Jian — Director
Shares
1,607
Price
$1.60
Total Value
$2.57K
Shares Held After
333,770
% of Holdings
0.5%
Xencor Inc (XNCR)
Cornelissen Bart Jan — SR. VICE PRESIDENT & CFO
Shares
2,517
Price
$11.25
Total Value
$28.30K
Shares Held After
79,397
% of Holdings
3.1%
Xencor Inc (XNCR)
Desjarlais John R — SR. VICE PRESIDENT & CSO
Shares
4,118
Price
$11.25
Total Value
$46.31K
Shares Held After
266,333
% of Holdings
1.5%
Metagenomi Therapeutics, Inc. (MGX)
Wein Matthew — Title: General Counsel, Compliance Officer and Corporate Secretary
Shares
482
Price
$1.60
Total Value
$771.20
Shares Held After
114,549
% of Holdings
0.4%
Rapport Therapeutics, Inc. (RAPP)
Gault Cheryl — Chief Operating Officer
Shares
2,014
Price
$28.93
Total Value
$58.27K
Shares Held After
169,914
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
587
Price
$487.98
Total Value
$286.45K
Shares Held After
130
% of Holdings
81.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,199
Price
$487.02
Total Value
$583.94K
Shares Held After
717
% of Holdings
62.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
798
Price
$486.20
Total Value
$387.99K
Shares Held After
1,916
% of Holdings
29.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,625
Price
$485.00
Total Value
$1.27M
Shares Held After
2,714
% of Holdings
49.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,728
Price
$484.05
Total Value
$836.44K
Shares Held After
5,339
% of Holdings
24.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,293
Price
$482.93
Total Value
$624.42K
Shares Held After
7,067
% of Holdings
15.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
510
Price
$482.05
Total Value
$245.84K
Shares Held After
8,360
% of Holdings
5.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
481
Price
$480.56
Total Value
$231.15K
Shares Held After
8,870
% of Holdings
5.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
279
Price
$479.89
Total Value
$133.89K
Shares Held After
9,351
% of Holdings
2.9%
Quantum-Si Inc (QSI)
Kummeth Charles R. — Director
Shares
500,000
Price
$0.92
Total Value
$459.80K
Shares Held After
855,000
% of Holdings
58.5%
Quantum-Si Inc (QSI)
Dowdy Paula — Director
Shares
109,890
Price
$0.95
Total Value
$104.45K
Shares Held After
269,107
% of Holdings
40.8%
PTC THERAPEUTICS, INC. (PTCT)
Golden Lee Scott — EVP & CHIEF MEDICAL OFFICER
Shares
10,000
Price
$63.38
Total Value
$633.80K
Shares Held After
79,944
% of Holdings
11.1%
Showing 551–600 of 3368 transactions (page 12 of 68)